Clinical profile of enteric fever: a prospective study of fifty enteric fever patients

Ashish Kakaria, Dilip Asgaonkar, Meenakshi Narkhede


Background: The protean manifestations of enteric fever make this disease a true diagnostic challenge. Untreated, typhoid fever is a grueling illness that may progress to delirium, obtundation, intestinal hemorrhage, bowel perforation, and death within 1 month of onset. Survivors may be left with long-term or permanent neuropsychiatric complications. This is a prospective study of fifty confirmed enteric fever adult patients done in Kasturba Hospital Mumbai.

Methods: Fifty enteric fever patients with clinical and laboratory diagnosis were included in the study. They were admitted in wards with the aim of documenting the epidemiological pattern, clinical picture, therapeutic response and complications of Salmonella. Their history and detailed physical examination were recorded and tests including antibiotic sensitivity and resistance were done.

Results: In the study incidence of fever 100%, chills 26%, vomiting 44%, diarrhea 28%, abdominal pain 64%, headache 26%, and signs as splenomegaly 36%, hepatomegaly 42%, rose spots 6%, relative bradycardia 34% were reported. Anemia, leukocytosis and leukopenia and elevated liver enzymes were found in 42.9%, 10%, 21% and 45% respectively. Incidence of Salmonella Typhi, Salmonella Paratyphi was 80% and 20% respectively. There was no mortality in the study.

Conclusion: Clinical presentation, signs and symptoms of Typhoid fever patients are varying. For the confirmatory diagnosis in addition to a high index of suspicion, Widal test and blood culture are required. For the proper treatment of Typhoid fever in view of emergence of resistant strains of S. Typhi antibiotic sensitivity and resistance test should be done whenever facilities available.



Salmonella, Typhoid, Paratyphoid, Blood culture, Enteric fever

Full Text:



Textbook of Public health and Community Medicine. By Department of Community Medicine, Armed Forces Medical College, Pune in collaboration with World Health Organization, India Office, New Delhi. first edition. 2009;1132-1134.

Cammie F. Lesser, Samuel I. Miller. Salmonellosis. Harrison’s principles of Internal Medicine. Volume 2. 16th edition. Edited by Kasper DL, Fauci AS, Longo DL, Brauwald E, Hauser SL, Jameson JL: New York: McGraw-Hill. 2005;897-901.

P.E.C. Manson-Bahr and D. R. Bell. Manson’s Tropical Diseases. Nineteenth edition. Baillier Tindall.1987; 201-202.

Nsutebu EF, Martins P, Adiogo D. Prevalence of typhoid fever in febrile patients with symptoms clinically compatible typhoid fever in Cameroon. Tropical Medicine and International Health. 2003; 8(6):575-8.

Gupta SP, Gupta MS, Bhardwaj S, Chugh TD. Current clinical patterns of typhoid fever: a prospective study. J Trop Med Hyg. 1985 Dec; 88(6):377-81.

YK Joshi, Clinical Features, Journal, Indian Academy of Clinical Medicine.Vol.2, No.1 and 2. Jan-Jun 2001; 13-15.

Christopher M. Parry, Tran Tinh Hien, Gordon Dougan, Nicholas J. White, and Jeremy J. Farrar. Typhoid FeverN Engl J Med. 2002; 347:1770-1782.

Bajracharya BL, Baral MR. Clinical profile and antibiotics response in typhoid fever. Kathmandu University Medical Journal. (2006); Vol. 4, No. 1, Issue 13, 25-29

Neopane A, Poudel M. Typhoid fever: Diagnostic value of clinical features. Kathmandu University Medical Journal (2006); Vol. 4, No. 3, Issue 15, 307-315.

Khosla SN, Anand A, Singh U, Khosla A. Haematological profile in typhoid fever. Trop Doct 1995; Oct; 25(4):156-8.

Krishnan P, Stalin M, Balasubramanian S. Changing trends in antimicrobial resistance of Salmonella enterica serovar typhi and salmonella enterica serovar paratyphi A in Chennai. Indian J Pathol Microbiol. 2009 Oct-Dec; 52(4):505-8.

Panicker CK, Vimla K M. Transferable chloramphenicol resistance in Salmonella Typhi. Nature 1973; 239:109

Easmon CSF, Crane IP, Blowers A. Effect of ciprofloxacin on intracellular organisms: In-vitro and in-vivo studies. J Antimicrob Chemother 1986; 8:696-9.

Alam MN, Haq SA, Das KK et al. Efficacy of ciprofloxacin in enteric fever: Comparison of treatment duration in sensitive and multidrug resistant Salmonella. Am J Trop Med Hyg 1995; 53:306-11.

Slinger R, Desjardins M, McCarthy AE, Ramotar K, Jessamine P, Guibord C, et al. Suboptimal clinical response to ciprofloxacin in patients with Typhoid fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series. BMC Infect Dis 2004; 4:36.

Wain J. Quinolone-resistant Salmonella typhi in Vietnam: Molecular basis of resistance and clinical response to treatment.Clin Infect Dis. 1997; 25:1404-10.

Slinger R, Desjardins M, McCarthy AE, Ramotar K, Jessamine P, Guibord C, et al. Suboptimal clinical response to ciprofloxacin in patients with Typhoid fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series. BMC Infect Dis 2004; 4:36.

Acharya G, Butler T, Ho M, et al. Treatment of typhoid fever: Randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol. Am J Trop Med Hyg.1995; 52:162-5.

Manchanda V, Bhalla P, Sethi M, Sharma VK. Treatment of Typhoid fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella Typhoida serovar typhi and paratyphi A. Indian J Med Microbiol 2006; 24:101-6.

Butler T. Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother. 1999; 44(2):243-50.